Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC
Clinical trial NCT06064279 · WITHDRAWN
Trial details
- NCT number
- NCT06064279
- Sponsor
- VA Office of Research and Development
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-04
- Primary completion
- 2024-06-04
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.